Quality of life in stroke survivors after local intra-arterial thrombolysis

Cerebrovascular Diseases

Volumn 25, Issue 5, 2008, Pages 438-444

  Fischer, Urs ^a   Anca, Diana ^a   Arnold, Marcel ^a   Nedeltchev, Krassen ^a   Kappeler, Liliane ^a   Ballinari, Pietro ^b   Schroth, Gerhard ^a   Mattle, Heinrich P ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Intra arterial thrombolysis; Outcome research; Quality of life; Stroke

Indexed keywords

UROKINASE;

ADULT; AGED; ARTICLE; BARTHEL INDEX; BASILAR ARTERY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISABILITY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; FUNCTIONAL STATUS; HOSPITAL ADMISSION; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANKIN SCALE; RATING SCALE; SCORING SYSTEM; SURVIVOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; STROKE; SURVIVAL RATE; SURVIVORS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR;

EID: 44449165592     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000126917     Document Type: Article

References (29)

1. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
2. Del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M, PROACT investigators: PROACT: a phase II randomized trial of recombinant pro-UK by direct arterial delivery in acute middle cerebral artery stroke. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4-11.
3. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F: Intra-arterial proUK for acute ischemic stroke - the PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-2011.
4. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607.
5. Mahoney FI, Barthel DW: Functional evaluation: the Barthel Index. Md State Med J 1965;14:61-65.
6. Guyatt GH, Feeny DH, Patrick DL: Measuring health-related quality of life. Ann Intern Med 1993;118:622-629.
7. Higashida R, Furlan A, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D, Society of Interventional Radiology, American Society of Interventional and Therapeutic Neuroradiology: Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. J Vasc Interv Radiol 2003;14:493-494.
8. Arnold M, Schroth G, Nedeltchev K, Loher T, Remonda L, Stepper F, Sturzenegger M, Mattle HP: Intraarterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 2002;33:1828-1833.
9. Arnold M, Nedeltchev K, Schroth G, Baumgartner RW, Remonda L, Loher TJ, Stepper F, Sturzenegger M, Schuknecht B, Mattle HP: Clinical and radiological predictors of recanalization and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry 2004;75:857-862.
10. Arnold M, Nedeltchev K, Mattle HP, Loher TJ, Stepper F, Schroth G, Brekenfeld C, Sturzenegger M, Remonda L: Intraarterial thrombolysis in 24 consecutive patients with internal carotid artery T occlusions. J Neurol Neurosurg Psychiatry 2003;74:739-742.
11. Fischer U, Arnold M, Nedeltchev K, Brekenfeld C, Ballinari P, Remonda L, Schroth G, Mattle HP: NIHSS score and arteriographic findings in acute ischemic stroke. Stroke 2005;36:2121-2125.
12. Arnold M, Nedeltchev K, Remonda L, Fischer U, Brekenfeld C, Keserue B, Schroth G, Mattle HP: Recanalisation of middle cerebral artery occlusion after intraarterial thrombolysis: different recanalisation grading systems and clinical functional outcome. J Neurol Neurosurg Psychiatry 2005;76:1373-1376.
13. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, Roorick M, Moomaw CJ, Walker M: Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:846-870.
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
15. Fischer U, Arnold M, Nedeltchev K, Schoenenberger RA, Kappeler L, Hollinger P, Schroth G, Ballinari P, Mattle HP: Impact of comorbidity on ischemic stroke outcome. Acta Neurol Scand 2006;113:108-113.
16. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE: Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke 1993;24:35-41.
17. TIMI Study Group: The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med 1985;312:932-936.
18. Hacke W, Kaste M, Bogousslavsky J, Brainin M, Chamorro A, Lees K, Leys D, Kwiecinski H, Toni P, Langhorne P, Diener C, Hennerici M, Ferro J, Sivenius J, Gunnar N, Bath P, Olsen TS, Gugging M, European Stroke Initiative Executive Committee and the EUSI Writing Committee: European Stroke Initiative (EUSI) recommendations for stroke management. Cerebrovasc Dis 2003;16:311-337.
19. EuroQol Group: A Measure of Health-Related Quality of Life Developed by the EuroQol Group. Rotterdam, EuroQol Group, 1996.
20. Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, Buxton M, Dolan P, Kind P, Krabbe P, Ohinmaa A, Parkin D, Roset M, Sintonen H, Tsuchiya A, deCharro F: A single European currency for EQ-5D health states: results from a six-country study. Eur J Health Econ 2003;4:222-231.
21. Dorman PJ, Waddell F, Slattery J, Dennis M, Sandercock P: Is the EuroQol a valid measure of health-related quality of life after stroke? Stroke 1997;28:1876-1882.
22. Dorman PJ, Waddell F, Slattery J, Dennis M, Sandercock P: Are proxy assessments of health status after stroke with the EuroQol questionnaire feasible, accurate, and unbiased? Stroke 1997;28:1883-1887.
23. Diringer MN, Ferran JM, Broderick J, Davis S, Mayer SA, Steiner T, Brun NC, Skolnick BE, Christensen MC: Impact of recombinant activated factor VII on health-related quality of life after intracerebral hemorrhage. Cerebrovasc Dis 2007;24:219-25.
24. Merino JG, Lattimore SU, Warach S: Telephone assessment of stroke outcome is reliable. Stroke 2005;36:232-233.
25. Lindsberg PJ, Soinne L, Tatlisumak T, Roine RO, Kallela M, Häppölä O, Kaste M: Long-term outcome after intravenous thrombolysis of basilar artery occlusion. JAMA 2004;292:1862-1866.
26. Sturm JW, Donnan GA, Dewey HM, Macdonell RAL, Gilligan AK, Srikanth V, Thrift AG: Quality of life after stroke: The North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2004;35:2340-2345.
27. King RB: Quality of life after stroke. Stroke 1996;27:1467-1472.
28. Thomassen L, Waje-Andreassen U, Naess H, Elvik MK, Russell D: Long-term effect of intravenous thrombolytic therapy in acute stroke: responder analysis versus uniform analysis of excellent outcome. Cerebrovasc Dis 2005;20:470-474.
29. Ahlsio B, Britton M, Murray V, Theorell T: Disablement and quality of life after stroke. Stroke 1984;15:886-890.